Skip to main content

LMR Partners LLP

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1578621 LONDON, X0

Position in BMRN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$18,355,804
+$17,216,056 QoQ
Shares Held
324,939
+1594.3% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$692,762
PutShares
9,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LMR Partners LLP holds $188,560,243 across 75 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in BMRN

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $18,355,804 324,939
2025-12-31 $1,139,748 19,178
2025-03-31 $692,762 9,800
2024-12-31 $644,154 9,800
2024-12-31 $290,395 4,418
2024-09-30 $7,717,842 109,800
2024-09-30 $5,282,152 75,148
2024-06-30 $10,136,222 123,117
2024-06-30 $18,524,250 225,000
2024-03-31 $24,455,200 280,000
2024-03-31 $6,829,988 78,200
2023-12-31 $7,540,044 78,200
2023-12-31 $22,658,700 235,000
2023-09-30 $9,732,800 110,000
2023-09-30 $6,756,775 76,365
2023-06-30 $9,534,800 110,000
2023-06-30 $3,034,753 35,011
2023-06-30 $3,380,520 39,000
2023-03-31 $7,236,503 74,419
2022-12-31 $5,891,168 56,925
2022-09-30 $4,652,601 54,885
2022-06-30 $2,979,425 35,953
2022-03-31 $6,985,491 90,603
2021-12-31 $3,105,944 35,155
2021-06-30 $658,758 7,895
2021-03-31 $596,151 7,895
2020-12-31 $2,499,165 28,500